We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Population-Scale Proteomics Study Identifies New Genetic-Protein Links

By LabMedica International staff writers
Posted on 06 Oct 2026

Population-scale proteomics is increasingly used to connect genetic variation, protein biology, and health-related traits in studies of complex human disease. More...

These efforts require both analytical depth and sufficient throughput to process large, diverse cohorts, which remains challenging in large-scale proteomic research. Building on this need, a new integrated proteomics approach combines complementary protein-measurement technologies to uncover previously unreported genetic-protein associations in a Singapore population health study.

In the PRECISE-SG100K study, a strategic collaboration involving Thermo Fisher Scientific, Precision Health Research, Singapore, and Nanyang Technological University, Singapore identified more than 2,500 previously unreported genetic-protein associations. Initial results, presented at the Human Proteome Organization (HUPO) World Congress, were based on analysis of the first 10,000 participant samples and combined Thermo Fisher proteomics technologies with PRECISE-SG100K genomic and health data.

The study integrates Olink Proximity Extension Assay (PEA) platforms with the Orbitrap Astral mass spectrometry system and Seer’s Proteograph Product Suite. The Orbitrap Astral platform supports deep discovery proteomics by measuring thousands of proteins directly at high throughput, while Olink PEA technology provides highly sensitive, targeted protein measurements. Together, these complementary approaches extend proteomic coverage and enable protein findings to be analyzed alongside genomic and health information.

Analysis of approximately 10,000 participant samples quantified about 8,800 protein groups. A genetic association analysis identified more than 4,200 proteins whose levels were linked to nearby genetic differences, including significant cis-protein quantitative trait loci. Among these findings, researchers identified 2,762 associations between genetic variation and protein levels that had not been reported across 12 reference studies used for comparison.

Researchers also linked proteins to 71 health-related traits, demonstrating how the integrated dataset could connect molecular findings with clinically relevant characteristics. These findings included identification and confirmation of the relationship between SOST/sclerostin, a biologically validated osteoporosis target, and bone mineral density. The integrated approach is intended to provide additional evidence for investigating disease pathways, potential biomarkers, and therapeutic targets.

The SG100K study has recruited more than 100,000 participants from Singapore’s diverse, multi-ethnic Asian population. It integrates genomic, proteomic, clinical, and other health information to provide insight into healthy states and disease biology. The study is designed to examine how genetics, environment, and lifestyle influence disease risk and treatment response, while addressing underrepresentation of diverse populations in biomedical and translational research.

Related Links
Nanyang Technological University
Precision Health Research


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

Cancer risk stratification in healthy adults often relies on established factors such as age and smoking history. However, several cancers highlighted in the study, including pancreatic, kidney, and brain... Read more

Molecular Diagnostics

view channel
Image: A blood test measuring circulating tumor DNA may help identify men with hormone-resistant oligoprogressive prostate cancer most likely to benefit from stereotactic body radiotherapy (Image Credit: Adobe Stock)

Blood Test Identifies Candidates for Targeted Radiotherapy in Advanced Prostate Cancer

Advanced prostate cancer can progress despite hormone-based treatment, with imaging sometimes revealing only limited areas of active disease. For men with hormone-resistant oligoprogressive prostate cancer,... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.